Sara Ghaffarpour, Azadeh Rashidi, Zeinab Ghazanfari, Hassan Ghasemi, Zohre Khodashenas, Poopak Izadi, Mohammad Mehdi Naghizadeh, Tooba Ghazanfari
Our findings imply significant disparities in immune responses between men and women, highlighting the complex interplay of sex and chemical exposure on health outcomes.
BACKGROUND: People exposed to sulfur mustard (SM), experience acute and chronic disorders primarily in the skin, eyes, and respiratory system. Here we examined sex differences in MCP-1, CXCL10, MMP-3, and MMP-9 in SM survivors and unexposed controls with and without definite lung, eye, and skin disorders.
METHODS: This research is a part of phase II of the SICS (Sardasht-Iran Cohort Study) and relates to the health screening performed 26 years post-exposure in SM survivors. In total, 489 subjects (361 men and 128 women) with a history of SM exposure, along with 137 age- and sex-matched unexposed controls (93 men and 44 women), constitute the study population. All participants underwent clinical evaluation by expert specialists. Serum concentrations of MCP-1, CXCL10, MMP-3, and MMP-9 were measured using the ELISA technique.
RESULTS: SM-exposed individuals showed significantly lower serum CXCL10 levels compared with unexposed controls, while MCP-1 and MMP-9 did not differ significantly at the total population level. MMP-3 also showed no significant unadjusted difference; however, multivariable regression, adjusting for the significant age difference between groups, revealed a significant exposure-associated reduction in MMP-3 (p < 0.001), indicating that age had masked this association in the unadjusted comparison. Sex-stratified analysis revealed that CXCL10 was consistently and significantly lower in both exposed men and women after FDR correction. MMP-3 was significantly higher in men than women, regardless of exposure status, with no significant exposure-related difference surviving FDR correction in either sex. MMP-9 exhibited a sex-dependent exposure effect: levels were significantly elevated in exposed men, whereas the decreasing trend observed in exposed women did not survive FDR adjustment. Among clinicopathological associations, lower MMP-3 was significantly associated with dermatological disorders in SM-exposed subjects. A borderline elevation of MMP-9 was observed in SM-exposed subjects with ocular disorders; however, this association did not survive FDR adjustment and requires cautious interpretation. No significant associations were identified between any biomarker and pulmonary disorders in either group.
CONCLUSION: Our findings imply significant disparities in immune responses between men and women, highlighting the complex interplay of sex and chemical exposure on health outcomes.